Skip to main content
Caplight Logo









Windward Bio

Private
BaselHealthcare & Life Sciences

Last Round

Series A

Jan 10, 2025

Total Funding Raised

$200M

Company Overview

Windward Bio operates in Healthcare & Life Sciences and is based in Basel. Its latest recorded funding round was a Series A round in January 2025.

Windward Bio is a biotechnology company that is a clinical-stage drug developer of treatments for people living with advanced immunological diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Windward Bio Comparables

Compare Windward Bio with similar companies based on industry and business-model similarity.

Windward Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Uniquity Bio
94%
Belenos Biosciences Inc.
85%
Upstream Bio
85%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Windward Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 10, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Windward Bio Investors

Notable investors and investment history

Windward Bio investors
InvestorRounds
Omega FundsSeries A
Blue Owl CapitalSeries A
OrbiMedSeries A
Pivotal bioVenture PartnersSeries A
Novo HoldingsSeries A
SR OneSeries A
Quan CapitalSeries A

Windward Bio Filings

Explore SEC and related filing metadata, where available.

Windward Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Windward Bio's valuation, stock price, and market status.

Is Windward Bio a public or private company?

Windward Bio is a private company.

What is the current stock price of Windward Bio?

Windward Bio is a private company, so its shares have no public market price. Caplight tracks Windward Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Windward Bio worth (valuation)?

Valuation information for Windward Bio is not publicly available.

Can I buy Windward Bio stock?

Windward Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Windward Bio's last funding round?

Windward Bio's most recent funding round was Series A on January 10, 2025.

Who are the main investors in Windward Bio?

Key investors in Windward Bio include Blue Owl Capital, OrbiMed, Novo Holdings.

Will Windward Bio IPO soon?

No public IPO plans have been announced for Windward Bio.

How can I track Windward Bio secondary market activity?

Caplight tracks bids, offers, and trades in Windward Bio's shares on secondary markets.

Firmographic Details

HeadquartersBasel
Year Founded2024
Last FundingJan 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?